Hims & Hers Health Reports Q3 2026 Results with Revenue and EPS Misses
Hims & Hers Health (NYSE: HIMS) reported third-quarter 2026 financial results that fell short of analyst expectations on both the top and bottom lines. The company posted a GAAP earnings per share (EPS) of -$0.14, missing estimates by $0.20, while revenue reached $890.3 million, slightly underperforming consensus by $2.47 million. Despite the misses, the company demonstrated significant growth in its user base, with subscribers increasing 13% year-over-year to nearly 2.8 million. However, the quarterly performance has led the company to tighten its full-year 2026 revenue guidance, signaling a more cautious outlook for the remainder of the fiscal year.
Tickers: $HIMS
Topics: earnings miss guidance revision revenue growth subscriber growth
Read the full article at Seeking Alpha
Part of the story Plains All American Pipeline misses top-line and bottom-line estimates; on track to deliver full-year 2026 outlook (3 articles)